Crossmark

Synthesis and Antimicrobial Evaluation of (E)-2-(4-((4-((1-(2,4-Dichlorophenyl)-3-methyl-5-oxo-1,5-dihydro-4H-pyrazol-4-ylidene)methyl)-2-methoxyphenoxy)methyl)-1H-1,2,3-triazol-1-yl)-N-phenylacetamide Derivatives

Crossref DOI link: https://doi.org/10.1134/S1068162025010091

Published Online: 2025-02-12

Published Print: 2025-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Mascarenhas, Cheryl T.

Wable, Jaidip B.

Akolkar, Hemantkumar N.

Darekar, Nirmala R.

Prabhu, Pradnya J.
License Information

Text and Data Mining valid from 2025-02-01

Version of Record valid from 2025-02-01
More Information

Article History

Received: 12 September 2024

Revised: 9 October 2024

Accepted: 12 October 2024

First Online: 12 February 2025

ETHICS APPROVAL AND CONSENT TO PARTICIPATE

: This article does not contain any studies involving patients or animals as test objects.

: Informed consent was not required for this article. No conflicts of interest was declared by the authors.

Document is current

Any future updates will be listed below